Schedule 13G ownership disclosure

Celldex Therapeutics, Inc.

Security class unavailable · CUSIP: 15117B103

Event date: 2021-02-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,015,513
Percent of class
5.0939%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-21-001052
Form type
SC 13G
Filer
Celldex Therapeutics, Inc.
CIK
CIK 744218
Filed
Feb 25, 2021
Reporting period
Feb 22, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub